R2.I.03/2022 - Investigador/a R2.I / Researcher R2.I (I-06)
Application Submission process
From: 27/05/2022 11:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris
To: 15/06/2022 12:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Info:
El laboratorio de Neurobiología ha alcanzado un nuevo acuerdo con la empresa sueca Umecrine para realizar el estudio: Effects of golexanolone on fatigue, itching, cognitive and motor function, liver damage, peripheral inflammation and allopregnanolone levels in a Bile Duct Ligation (BDL) model of cholestasis in rats, financiado por Umecrine. Esto supone un incremento ocasional imprevisto de trabajo, que hace necesario contratar una persona que participará en la realización de este estudio durante un periodo de 3 meses
.........................................................
The Laboratory of Neurobiology has reached a new agreement with the Swedish company Umecrine to perform the study: Effects of golexanolone on fatigue, itching, cognitive and motor function, liver damage, peripheral inflammation and allopregnanolone levels in a Bile Duct Ligation (BDL) model of cholestasis in rats, with the support of Umecrine. This implies an occasional and unforeseen increase of work which makes necessary to contract a person who will participate in this study for a period of 3 months
Call Document
Resolución oferta de empleo R2.I.03/2022 - Job Offer Resolution R2.I.03/2022
For your safety, your session will be closed in
60